Celldex Therapeutics - 51 Year Dividend History | CLDX

Historical dividend payout and yield for Celldex Therapeutics (CLDX) since 1971. The current TTM dividend payout for Celldex Therapeutics (CLDX) as of May 25, 2022 is $0.00. The current dividend yield for Celldex Therapeutics as of May 25, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.262B $0.005B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio